AVEO said on March 6, “We believe these data suggest a promising new development path forward in a significant patient population.” Does any body have any status update on the path forward?
We need a buyout or partnership for sure, but 50 DMA is getting ready to Cross the 200 DMA. Somebodies must know something that we don't.
Good observation! The name of the game is to pass $1.6. I will tell you why $1.6 is so important when it happens.
Based on your info, MLV can now sell 14,569,026 shares (66,569,026 authorized limit - 52M O/S,) which would bring forth $20 million working capital to the company in a month or less.
I think the questions you need to ask is "Has MLV completed the sales of all the shares for AVEO? If not, what would be the remaining amount MLV has to raise for AVEO? I estimated they have to $12 M worth of shares. What do you think?
Based on the info you provided before, the company had planned to raise $17,900,000. 8 million shares, left to sell, worth about $12,000,000; in other words, the company had raised $6,000,000 so far. Is my interpretation correct?
20 hours ago, you said "We have entered into an At Market Issuance Sales Agreement, or sales agreement, with MLV & Co. LLC, or MLV, relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock from time to time through MLV, acting as agent, having an aggregate offering price of up to $17,900,000.
this is from sec filing............" Less